[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367531-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367531-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","economic-burden-of-five-common-cancers-in-iran-a-systematic-review-of-cost-of-illness-with-a-focus-on-healthcare-resource-utilization","Economic burden of five common cancers in Iran - a systematic review of cost-of-illness with a focus on healthcare resource utilization","","Economic burden of five common cancers in Iran is assessed through a systematic review targeting healthcare resource utilization. The review addresses gastric, breast, colorectal, lung, and prostate cancers, which account for nearly half of new cancer cases in Iran and generate substantial direct medical costs, direct non-medical costs, and indirect costs. Following PRISMA-guided methods and converting results to USD 2021, 22 eligible studies are synthesized, comparing cost ranges and identifying drivers such as resource utilization and calculation approaches. Conclusions emphasize significant financial strain and the need for policy action.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/economic-burden-of-five-common-cancers-in-iran-a-systematic-review-of-cost-of-illness-with-a-focus-on-healthcare-resource-utilization/367531/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/economic-burden-of-five-common-cancers-in-iran-a-systematic-review-of-cost-of-illness-with-a-focus-on-healthcare-resource-utilization/367531.png","ImageObject",300,407,{"name":42,"@type":43},"Fahsai","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which five cancers are included in the systematic review of Iran’s economic burden?","Question",{"text":63,"@type":64},"The review includes gastric, breast, colorectal, lung, and prostate cancer. These five cancers account for nearly half of new cancer cases in Iran, according to cited WHO-related context.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the review standardize cost estimates across different studies?",{"text":68,"@type":64},"Costs from included studies were converted to USD 2021 using the CCEMG-EPPI-Centre cost converter, enabling comparison of annual cost burdens.",{"name":70,"@type":61,"acceptedAnswer":71},"What factors are suggested to explain variations in reported costs?",{"text":72,"@type":64},"Variations may reflect differences in healthcare resource utilization, but also differences in cost calculation methodology, study perspective, and study location.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367531,1790325142,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","Irandoust etal. BMC Health Services Research (2025) 25:800 BMC Health Services Research  \n[https://doi.org/10.1186/s12913-025-12744-3](https://doi.org/10.1186/s12913-025-12744-3)  \nSYSTEMATIC REVIEW Open Access  \nEconomic burden of five common cancersin Iran: a systematic review of cost-of-illness with a focus on healthcare resource utilization  \nKamran Irandoust 1*, Vahid Alipour 1*, Jalal Arabloo2, Azin Nahvijou3 and Akram Akbari4  \nAbstract  \nBackground According to the latest World Health Organization report, approximately half of the new cancer cases in Iran are attributed to five common cancers: gastric, breast, colorectal, lung, and prostate cancer. These cancers impose a heavy economic burden on healthcare systems and society, including direct medical costs (DMC), direct non-medical costs (DNMC), and indirect costs (IDC) . This systematic review aimed to investigate the economic burden of these cancers in Iran.  \nMethods This systematic review was conducted according to PRISMA guidelines. The search strategy was developed using MeSH terms, Emtree, and previous literature. To identify relevant studies published up until December 27, 2023, searches were conducted in both international databases (PubMed, Scopus, Web of Science, Embase, Cochrane, and the NHS Economic Evaluation Database) and national databases (SID, Magiran, and IranMedex) . After removing duplicates and screening studies using Endnote software, eligible studies were selected for inclusion in the review. The costs were converted to USD 2021 using the CCEMG-EPPI-Centre cost converter.  \nResults A total of 22 studies were included in this review. Breast and colorectal cancer each had 4 studies, while prostate, gastric, and lung cancer each had 3 studies. The remaining 5 studies covered a combination of multiple cancers. Converting the costs from different studies to USD 2021 showed that the average annual DMC per patient with breast cancer varied from $13,954 to $34,772 . These costs ranged from $14,671 to $28,656 for colorectal cancer,$7,970 to $16,821 for prostate cancer, $12,206 to $17,681 for gastric cancer, and $9,369 to $40,682 for lung cancer.  \nPart of these variations may be related to differences in healthcare resource utilization, while another part may be due to differences in cost calculation methodology, study perspective, and study location. Additional cost conversion findings showed that in 85% of the studies, the average annual DNMC per patient for all cancers were estimated to be less than $4,000 . Furthermore, the average annual IDC per patient for breast and lung cancer were estimated to be as high as $100,000 due to high mortality, compared to less than $30,000 for other cancers.  \nConclusions Given the high prevalence of these five cancers in Iran, their economic burden is significant. Policymakers should focus not only on reducing the disease burden but also on minimizing the economic burden  \n*Correspondence: Kamran Irandoust[irandoust.k@iums.ac.ir](irandoust.k@iums.ac.ir)[ ](irandoust.k@iums.ac.ir)Vahid Alipour [alipour.v@iums.ac.ir](alipour.v@iums.ac.ir)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not","cbCaiu9gwLXYkIPI","https://ap.wps.com/l/cbCaiu9gwLXYkIPI","pdf",2221634,22,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n# Keywords","[{\"question\":\"Which five cancers are included in the systematic review of Iran’s economic burden?\",\"answer\":\"The review includes gastric, breast, colorectal, lung, and prostate cancer. These five cancers account for nearly half of new cancer cases in Iran, according to cited WHO-related context.\"},{\"question\":\"How did the review standardize cost estimates across different studies?\",\"answer\":\"Costs from included studies were converted to USD 2021 using the CCEMG-EPPI-Centre cost converter, enabling comparison of annual cost burdens.\"},{\"question\":\"What factors are suggested to explain variations in reported costs?\",\"answer\":\"Variations may reflect differences in healthcare resource utilization, but also differences in cost calculation methodology, study perspective, and study location.\"}]","Economic burden of five common cancers in Iran - a systematic review of cost-of-illness with a focus on healthcare resource utilization | PDF",1790171230,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/018f7dd740c92a5f61a6fdf7f993243a.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f270b238d967a10b31d33726a3e23e86.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e92396380a168c341d81785a289efdce.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a81feb4d897a0db4a578d36ecdc6079c.webp",980,1306]